Follow
Bernard Le Foll
Bernard Le Foll
University of Toronto; Centre for Addiction and Mental Health; Waypoint Centre for Mental Health
Verified email at camh.ca
Title
Cited by
Cited by
Year
The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies
S Lev-Ran, M Roerecke, B Le Foll, TP George, K McKenzie, J Rehm
Psychological medicine 44 (4), 797-810, 2014
6502014
Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations
B Fischer, C Russell, P Sabioni, W Van Den Brink, B Le Foll, W Hall, ...
American journal of public health 107 (8), e1-e12, 2017
4992017
Genetics of dopamine receptors and drug addiction: a comprehensive review
B Le Foll, A Gallo, Y Le Strat, L Lu, P Gorwood
Behavioural pharmacology 20 (1), 1-17, 2009
4702009
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders
P Sokoloff, J Diaz, BL Foll, O Guillin, L Leriche, E Bezard, C Gross
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006
4292006
Cannabis use and cannabis use disorder
JP Connor, D Stjepanović, B Le Foll, E Hoch, AJ Budney, WD Hall
Nature Reviews Disease Primers 7 (1), 16, 2021
4092021
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons
J Diaz, C Pilon, B Le Foll, C Gros, A Triller, JC Schwartz, P Sokoloff
Journal of Neuroscience 20 (23), 8677-8684, 2000
4082000
Psychosocial interventions for cannabis use disorder
PJ Gates, P Sabioni, J Copeland, B Le Foll, L Gowing
Cochrane database of systematic reviews, 2016
3922016
Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States
Y Le Strat, C Dubertret, B Le Foll
Journal of affective disorders 135 (1-3), 128-138, 2011
3642011
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll, SR Goldberg
Journal of Pharmacology and Experimental Therapeutics 312 (3), 875-883, 2005
3522005
Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis
S Nielsen, P Sabioni, JM Trigo, MA Ware, BD Betz-Stablein, B Murnion, ...
Neuropsychopharmacology 42 (9), 1752-1765, 2017
2932017
Identification of dopamine D1–D3 receptor heteromers: indications for a role of synergistic D1–D3 receptor interactions in the striatum
D Marcellino, S Ferré, V Casadó, A Cortés, B Le Foll, C Mazzola, F Drago, ...
Journal of Biological Chemistry 283 (38), 26016-26025, 2008
2922008
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study
M Yücel, E Oldenhof, SH Ahmed, D Belin, J Billieux, H Bowden‐Jones, ...
Addiction 114 (6), 1095-1109, 2019
2792019
Nicotine induces conditioned place preferences over a large range of doses in rats
B Le Foll, SR Goldberg
Psychopharmacology 178, 481-492, 2005
2792005
The dopamine D3 receptor, a quarter century later
P Sokoloff, B Le Foll
European Journal of Neuroscience 45 (1), 2-19, 2017
2422017
Child marriage in the United States and its association with mental health in women
Y Le Strat, C Dubertret, B Le Foll
Pediatrics 128 (3), 524-530, 2011
2382011
Tobacco and nicotine use
B Le Foll, ME Piper, CD Fowler, S Tonstad, L Bierut, L Lu, P Jha, WD Hall
Nature Reviews Disease Primers 8 (1), 19, 2022
2352022
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
2152013
The dopamine D3 receptor and drug dependence: effects on reward or beyond?
B Le Foll, SR Goldberg, P Sokoloff
Neuropharmacology 49 (4), 525-541, 2005
2152005
Effects of nicotine in experimental animals and humans: an update on addictive properties
BL Foll, SR Goldberg
Nicotine Psychopharmacology, 335-367, 2009
2132009
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
B Le Foll, SR Goldberg
Neuroreport 15 (13), 2139-2143, 2004
2132004
The system can't perform the operation now. Try again later.
Articles 1–20